Goise,
many of the cytokines are elevated in different diseases, and the cytokine storm is not unique to Covid. There are many drugs that target individual cytokines, including some for Covid being trialled and used, such as remdesivir. The WHO is now recommending the release of IL-6 inhibitors for severe C19 patients, one of which is Tocilizumab, also used for Arthritis. https://www.who.int/news/item/06-07-2021-who-recommends-life-saving-interleukin-6-receptor-blockers-for-covid-19-and-urges-producers-to-join-efforts-to-rapidly-increase-access
There are also others, most notably Viroporin Inhibitors that are being trialled for C-19. So as you can see, it is a real mix and match.
In short, these abovementioned drugs work against increased levels of IL-6, which is present within many inflamations, arthritis included.
So we can't categorically rule out what else that 225 may be used for in the future, but presently we need to stick to HIV and C-19.
- Forums
- ASX - By Stock
- BIT
- BIT036- a likely candidate for curing COVID-19
BIT036- a likely candidate for curing COVID-19, page-943
-
-
- There are more pages in this discussion • 1,124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $20.75M |
Open | High | Low | Value | Volume |
2.1¢ | 2.4¢ | 2.1¢ | $22.42K | 1.006M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 145000 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 262553 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 145000 | 0.021 |
13 | 812211 | 0.020 |
11 | 2065201 | 0.019 |
10 | 1719892 | 0.018 |
6 | 614520 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 262553 | 3 |
0.025 | 250000 | 2 |
0.026 | 53847 | 1 |
0.027 | 162000 | 2 |
0.029 | 316026 | 1 |
Last trade - 15.59pm 21/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online